DLB vs LB
Dolby Laboratories, Inc. and LandBridge Corp., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DLB | LB |
|---|---|---|
| Revenue | $1.3B | $199.1M |
| Net income | $255.0M | $30.1M |
| Gross margin | 88.1% | · |
| Net margin | 19.0% | 36.4% |
| Return on equity | 10.0% | 10.9% |
| Diluted EPS | $2.62 | $0.94 |
| Dividend / share | $1.32 | · |
| Payout ratio | 49.6% | 211.5% |
| Free cash flow | $435.9M | $122.0M |
| Equity | $2.6B | $340.3M |
| Net debt / equity | · | 1.56× |
| Current ratio | 3.17× | 4.87× |
| Revenue CAGR 5y | 3.0% | · |
| Profit CAGR 5y | 2.0% | · |
DLB bills 6.8× the revenue of LB, and LB keeps more of each dollar of revenue as profit (36.4% against 19.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
3 years side by side
| Fiscal year | DLB | LB |
|---|---|---|
| FY2025 | $1.3B | $199.1M |
| FY2024 | $1.3B | $110.0M |
| FY2023 | $1.3B | $72.9M |
Bottom line
| Fiscal year | DLB | LB |
|---|---|---|
| FY2025 | $255.0M | $30.1M |
| FY2024 | $261.8M | $5.1M |
| FY2023 | $200.7M | $63.2M |
Standard deviation, each side
LB's net margin has been more volatile than DLB's over the 3 comparable fiscal years — 51.1 percentage points of standard deviation against 2.2.
3 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DLB and LB over these 3 fiscal years — DLB led in 1 and LB in 2.
3 of 18 comparable fiscal years — a year missing data on either side is not counted.